↓ Skip to main content

Recurrent Melioidosis in the Darwin Prospective Melioidosis Study: Improving Therapies Mean that Relapse Cases Are Now Rare

Overview of attention for article published in Journal of Clinical Microbiology, November 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter
1 X user
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
43 Dimensions

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Recurrent Melioidosis in the Darwin Prospective Melioidosis Study: Improving Therapies Mean that Relapse Cases Are Now Rare
Published in
Journal of Clinical Microbiology, November 2013
DOI 10.1128/jcm.02239-13
Pubmed ID
Authors

Derek S. Sarovich, Linda Ward, Erin P. Price, Mark Mayo, Matthew C. Pitman, Robert W. Baird, Bart J. Currie

Abstract

The Darwin Prospective Melioidosis Study has documented 785 melioidosis cases over 23 years. Recurrent melioidosis occurred in 39/679 (5.7%) patients surviving initial infection; 29 patients suffered relapse of the original infection, and 10 presented with a new Burkholderia pseudomallei infection. With improved therapy, relapse has become rare in recent years.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Thailand 1 3%
Unknown 38 95%

Demographic breakdown

Readers by professional status Count As %
Other 8 20%
Student > Master 7 18%
Student > Ph. D. Student 5 13%
Researcher 3 8%
Student > Postgraduate 3 8%
Other 6 15%
Unknown 8 20%
Readers by discipline Count As %
Medicine and Dentistry 12 30%
Agricultural and Biological Sciences 7 18%
Biochemistry, Genetics and Molecular Biology 5 13%
Immunology and Microbiology 3 8%
Nursing and Health Professions 2 5%
Other 3 8%
Unknown 8 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 December 2020.
All research outputs
#7,960,052
of 25,373,627 outputs
Outputs from Journal of Clinical Microbiology
#5,952
of 14,317 outputs
Outputs of similar age
#87,976
of 319,987 outputs
Outputs of similar age from Journal of Clinical Microbiology
#24
of 87 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 14,317 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 319,987 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 87 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.